Global Insomnia Drugs Market

Global Insomnia Drugs Market Research Report 2021

Global Insomnia Drugs Market

Global Insomnia Drugs Market Research Report 2021


Insights into the Insomnia Drugs Market include supply chain optimization, Insomnia Drugs challenges, and growth forecasts segmented by region and service type.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Research Predicts that Insomnia Drugs Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.

Global Insomnia Drugs Market Overview:

Global Insomnia Drugs Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Insomnia Drugs involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

Impact of COVID-19 on Insomnia Drugs Market

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Insomnia Drugs market in 2020.

Global Insomnia Drugs Market Segmentation

By Type, Insomnia Drugs market has been segmented into:

Tablets

Capsules

By Application, Insomnia Drugs market has been segmented into:

Adults

Children

Regional Analysis:

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Top Key Players Covered in Insomnia Drugs market are:

Eisai

Merck

Pfizer

Sanofi

Takeda

Astellas

Biocodex

Dainippon Sumitomo

ECR Pharmaceuticals

Fidia Farmaceutici

Flynn Pharma

Johnson & Johnson

Juste

Meda

Pernix Therapeutics

Purdue Pharma

Vanda Pharmaceuticals

1. Market Overview of Insomnia Drugs

1.1 Insomnia Drugs Market Overview

1.1.1 Insomnia Drugs Product Scope

1.1.2 Market Status and Outlook

1.2 Insomnia Drugs Market Size by Regions: 2015 VS 2021 VS 2026

1.3 Insomnia Drugs Historic Market Size by Regions (2015-2020)

1.4 Insomnia Drugs Forecasted Market Size by Regions (2021-2026)

1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)

1.5.1 North America

1.5.2 East Asia

1.5.3 Europe

1.5.4 South Asia

1.5.5 Southeast Asia

1.5.6 Middle East

1.5.7 Africa

1.5.8 Oceania

1.5.9 South America

1.5.10 Rest of the World

1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.6.2 Covid-19 Impact: Commodity Prices Indices

1.6.3 Covid-19 Impact: Global Major Government Policy

2. Covid-19 Impact Insomnia Drugs Sales Market by Type (2015-2026)

2.1 Global Insomnia Drugs Historic Market Size by Type (2015-2020)

2.2 Global Insomnia Drugs Forecasted Market Size by Type (2021-2026)

2.3 Tablets

2.4 Capsules

3. Covid-19 Impact Insomnia Drugs Sales Market by Application (2015-2026)

3.1 Global Insomnia Drugs Historic Market Size by Application (2015-2020)

3.2 Global Insomnia Drugs Forecasted Market Size by Application (2021-2026)

3.3 Adults

3.4 Children

4. Covid-19 Impact Market Competition by Manufacturers

4.1 Global Insomnia Drugs Production Capacity Market Share by Manufacturers (2015-2020)

4.2 Global Insomnia Drugs Revenue Market Share by Manufacturers (2015-2020)

4.3 Global Insomnia Drugs Average Price by Manufacturers (2015-2020)

5. Company Profiles and Key Figures in Insomnia Drugs Business

5.1 Eisai

5.1.1 Eisai Company Profile

5.1.2 Eisai Insomnia Drugs Product Specification

5.1.3 Eisai Insomnia Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.2 Merck

5.2.1 Merck Company Profile

5.2.2 Merck Insomnia Drugs Product Specification

5.2.3 Merck Insomnia Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.3 Pfizer

5.3.1 Pfizer Company Profile

5.3.2 Pfizer Insomnia Drugs Product Specification

5.3.3 Pfizer Insomnia Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.4 Sanofi

5.4.1 Sanofi Company Profile

5.4.2 Sanofi Insomnia Drugs Product Specification

5.4.3 Sanofi Insomnia Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.5 Takeda

5.5.1 Takeda Company Profile

5.5.2 Takeda Insomnia Drugs Product Specification

5.5.3 Takeda Insomnia Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.6 Astellas

5.6.1 Astellas Company Profile

5.6.2 Astellas Insomnia Drugs Product Specification

5.6.3 Astellas Insomnia Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.7 Biocodex

5.7.1 Biocodex Company Profile

5.7.2 Biocodex Insomnia Drugs Product Specification

5.7.3 Biocodex Insomnia Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.8 Dainippon Sumitomo

5.8.1 Dainippon Sumitomo Company Profile

5.8.2 Dainippon Sumitomo Insomnia Drugs Product Specification

5.8.3 Dainippon Sumitomo Insomnia Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.9 ECR Pharmaceuticals

5.9.1 ECR Pharmaceuticals Company Profile

5.9.2 ECR Pharmaceuticals Insomnia Drugs Product Specification

5.9.3 ECR Pharmaceuticals Insomnia Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.10 Fidia Farmaceutici

5.10.1 Fidia Farmaceutici Company Profile

5.10.2 Fidia Farmaceutici Insomnia Drugs Product Specification

5.10.3 Fidia Farmaceutici Insomnia Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.11 Flynn Pharma

5.11.1 Flynn Pharma Company Profile

5.11.2 Flynn Pharma Insomnia Drugs Product Specification

5.11.3 Flynn Pharma Insomnia Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.12 Johnson & Johnson

5.12.1 Johnson & Johnson Company Profile

5.12.2 Johnson & Johnson Insomnia Drugs Product Specification

5.12.3 Johnson & Johnson Insomnia Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.13 Juste

5.13.1 Juste Company Profile

5.13.2 Juste Insomnia Drugs Product Specification

5.13.3 Juste Insomnia Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.14 Meda

5.14.1 Meda Company Profile

5.14.2 Meda Insomnia Drugs Product Specification

5.14.3 Meda Insomnia Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.15 Pernix Therapeutics

5.15.1 Pernix Therapeutics Company Profile

5.15.2 Pernix Therapeutics Insomnia Drugs Product Specification

5.15.3 Pernix Therapeutics Insomnia Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.16 Purdue Pharma

5.16.1 Purdue Pharma Company Profile

5.16.2 Purdue Pharma Insomnia Drugs Product Specification

5.16.3 Purdue Pharma Insomnia Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.17 Vanda Pharmaceuticals

5.17.1 Vanda Pharmaceuticals Company Profile

5.17.2 Vanda Pharmaceuticals Insomnia Drugs Product Specification

5.17.3 Vanda Pharmaceuticals Insomnia Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)

6. North America

6.1 North America Insomnia Drugs Market Size (2015-2026)

6.2 North America Insomnia Drugs Key Players in North America (2015-2020)

6.3 North America Insomnia Drugs Market Size by Type (2015-2020)

6.4 North America Insomnia Drugs Market Size by Application (2015-2020)

7. East Asia

7.1 East Asia Insomnia Drugs Market Size (2015-2026)

7.2 East Asia Insomnia Drugs Key Players in North America (2015-2020)

7.3 East Asia Insomnia Drugs Market Size by Type (2015-2020)

7.4 East Asia Insomnia Drugs Market Size by Application (2015-2020)

8. Europe

8.1 Europe Insomnia Drugs Market Size (2015-2026)

8.2 Europe Insomnia Drugs Key Players in North America (2015-2020)

8.3 Europe Insomnia Drugs Market Size by Type (2015-2020)

8.4 Europe Insomnia Drugs Market Size by Application (2015-2020)

9. South Asia

9.1 South Asia Insomnia Drugs Market Size (2015-2026)

9.2 South Asia Insomnia Drugs Key Players in North America (2015-2020)

9.3 South Asia Insomnia Drugs Market Size by Type (2015-2020)

9.4 South Asia Insomnia Drugs Market Size by Application (2015-2020)

10. Southeast Asia

10.1 Southeast Asia Insomnia Drugs Market Size (2015-2026)

10.2 Southeast Asia Insomnia Drugs Key Players in North America (2015-2020)

10.3 Southeast Asia Insomnia Drugs Market Size by Type (2015-2020)

10.4 Southeast Asia Insomnia Drugs Market Size by Application (2015-2020)

11. Middle East

11.1 Middle East Insomnia Drugs Market Size (2015-2026)

11.2 Middle East Insomnia Drugs Key Players in North America (2015-2020)

11.3 Middle East Insomnia Drugs Market Size by Type (2015-2020)

11.4 Middle East Insomnia Drugs Market Size by Application (2015-2020)

12. Africa

12.1 Africa Insomnia Drugs Market Size (2015-2026)

12.2 Africa Insomnia Drugs Key Players in North America (2015-2020)

12.3 Africa Insomnia Drugs Market Size by Type (2015-2020)

12.4 Africa Insomnia Drugs Market Size by Application (2015-2020)

13. Oceania

13.1 Oceania Insomnia Drugs Market Size (2015-2026)

13.2 Oceania Insomnia Drugs Key Players in North America (2015-2020)

13.3 Oceania Insomnia Drugs Market Size by Type (2015-2020)

13.4 Oceania Insomnia Drugs Market Size by Application (2015-2020)

14. South America

14.1 South America Insomnia Drugs Market Size (2015-2026)

14.2 South America Insomnia Drugs Key Players in North America (2015-2020)

14.3 South America Insomnia Drugs Market Size by Type (2015-2020)

14.4 South America Insomnia Drugs Market Size by Application (2015-2020)

15. Rest of the World

15.1 Rest of the World Insomnia Drugs Market Size (2015-2026)

15.2 Rest of the World Insomnia Drugs Key Players in North America (2015-2020)

15.3 Rest of the World Insomnia Drugs Market Size by Type (2015-2020)

15.4 Rest of the World Insomnia Drugs Market Size by Application (2015-2020)

16 Insomnia Drugs Market Dynamics

16.1 Covid-19 Impact Market Top Trends

16.2 Covid-19 Impact Market Drivers

16.3 Covid-19 Impact Market Challenges

16.4 Porter’s Five Forces Analysis

18 Regulatory Information

17 Analyst's Viewpoints/Conclusions

18 Appendix

18.1 Research Methodology

18.1.1 Methodology/Research Approach

18.1.2 Data Source

18.2 Disclaimer

Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Insomnia Drugs Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Who are the dominant players having a strong presence in the Insomnia Drugs Market?
Some of the finest and top-notch companies pioneering the Insomnia Drugs Market are Eisai, Merck, Pfizer, Sanofi, Takeda, Astellas, Biocodex, Dainippon Sumitomo, ECR Pharmaceuticals, Fidia Farmaceutici, Flynn Pharma, Johnson & Johnson, Juste, Meda, Pernix Therapeutics, Purdue Pharma, Vanda Pharmaceuticals.
How is the competition changing gears in the Insomnia Drugs Industry?
Emerging markets will create new demands and put pressure on the industry to act quickly. Simultaneously, market players such as Eisai, Merck, Pfizer, Sanofi, Takeda, Astellas, Biocodex, Dainippon Sumitomo, ECR Pharmaceuticals, Fidia Farmaceutici, Flynn Pharma, Johnson & Johnson, Juste, Meda, Pernix Therapeutics, Purdue Pharma, Vanda Pharmaceuticals will face challenges from the industry's increasing pace of consolidation, particularly in North America and Europe.
What important business segments are segregated by application types in the latest edition of the Insomnia Drugs Market?
The key business segments in the Insomnia Drugs Market are segregated by applications [Adults, Children] and types [Tablets, Capsules].
What is the size of the Insomnia Drugs Industry?
According to the report, the Insomnia Drugs Industry will grow to USD XXX Million by 2030, with a YY% CAGR.
What does the future hold for the Insomnia Drugs Market?
As the shift to value addition continues, companies in the Insomnia Drugs Market face the dual challenge of improving interoperability to optimize performance and experience.
What are the top priorities for the growth of the Insomnia Drugs Market?
In this highly competitive and rapidly evolving Insomnia Drugs Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.